PRL and hypogonadism: This increased risk is associated not so much with PRL oversecretion but rather with the adverse effects of PRL on the hypothalamus-pituitary-gonad axis, which manifest as menstruation abnormalities and abnormal estradiol levels in women and testosterone deficit and hypogonadism-induced metabolic sequelae in men [8].